Cargando…

IBD in the Time of COVID19

Detalles Bibliográficos
Autores principales:	Moss, Alan, Regueiro, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184458/ http://dx.doi.org/10.1093/crocol/otaa029

Ejemplares similares

Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
por: Horst, Sara
Publicado: (2021)

IBD in the elderly - beware of pitfalls!
por: Sharip, Mohmmed T., et al.
Publicado: (2023)

Diet and Nutrition in IBD—Progress and Gaps
por: Raman, Maitreyi, et al.
Publicado: (2019)

Addressing Mental Health in Persons with IBD
por: Bernstein, Charles N
Publicado: (2018)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

“Diet in the Etiopathogenesis of IBD: Is There A Culinary Culprit?”
por: Issokson, Kelly
Publicado: (2020)

Epidemiology and Natural History of IBD in the Paediatric Age
por: Guariso, Graziella, et al.
Publicado: (2014)

Personalized management of IBD; is there any practical approach?
por: Norouzinia, Mohsen, et al.
Publicado: (2015)

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic. Authors' reply
por: King, Dominic Stephen, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with IBD
por: Segal, Jonathan P, et al.
Publicado: (2020)

JAK Inhibitors: Back to Small Molecules for the Treatment of IBD
por: Panés, Julian, et al.
Publicado: (2020)

Using IBD-REFER: A Substitute for Clinical Judgement?
por: Dueker, Jeffrey M, et al.
Publicado: (2020)

Managing IBD in the COVID-19 era
por: Scalzo, Nicholas, et al.
Publicado: (2023)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Implications of recurrent SARS-CoV-2 outbreaks for IBD management
por: Segal, Jonathan P, et al.
Publicado: (2020)

Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic
por: D’Amico, Ferdinando, et al.
Publicado: (2020)

Personalised medicine in IBD: don’t dispose of the sledgehammer just yet
por: Kumar, Aditi, et al.
Publicado: (2022)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Are Patient Self-reported Healthcare Utilization Data Reliable in Persons With IBD?
por: El-Matary, Wael
Publicado: (2021)

Impact of Different Nutrition Strategies on Patients with Inflammatory Bowel Disease (IBD)
por: Papadimitriou, Konstantinos, et al.
Publicado: (2023)

Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
por: Proietti, E, et al.
Publicado: (2021)

IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
por: Le, Peter N., et al.
Publicado: (2015)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Prevention of COVID-19 in patients with IBD – Authors' reply
por: Ding, Nik Sheng, et al.
Publicado: (2020)

IBD in the COVID-19 era: the value of international collaboration
por: Brenner, Erica J, et al.
Publicado: (2020)

Excessive anxiety in IBD patients is unnecessary for COVID-19
por: Wang, Hong-Gang, et al.
Publicado: (2020)

Protecting patients with IBD during the COVID-19 pandemic
por: Fiorino, Gionata, et al.
Publicado: (2020)

COVID-19—from mucosal immunology to IBD patients
por: Weidinger, Carl, et al.
Publicado: (2021)

COVID-19: Colorectal cancer endoscopic surveillance in IBD
por: Din, Shahida, et al.
Publicado: (2021)

Psychological reaction to Covid-19 of Italian patients with IBD
por: Savarese, Mariarosaria, et al.
Publicado: (2021)

Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity
por: Hindson, Jordan
Publicado: (2022)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Zooming in on Inflammatory Bowel Disease: Microbial and Proteomic Features Associated With IBD in Colonic Microenvironments
por: Tamburini, Sabrina, et al.
Publicado: (2016)

T-Cell Specificity Matters in IBD: Impaired IL10 Production Revealed by OmpC-Tetramers
por: Cook, Laura, et al.
Publicado: (2020)

Going Viral: Management of IBD in the Era of the COVID-19 Pandemic
por: Gutin, Liat S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0tr6pj748dooli7fco4ma1hp4t